|
2319
|
L 002
|
Inhibitor of p300 HAT (KAT3B) and p53 acetylation |
€80.00 |
|
1127
|
L 454560
|
PDE4 inhibitor |
€165.00 |
|
1196
|
L 838417
|
GABAA-α1 antagonist |
€95.00 |
|
2549
|
L67
|
Cytotoxic inhibitor of DNA ligase I and III |
€90.00 |
|
1444
|
Lacosamide
|
Na+ channel blocker; anti-convulsant |
€75.00 |
|
1353
|
Lamotrigine
|
Glutamate antagonist; Na+ channel blocker |
€60.00 |
|
1395
|
Lapatinib ditosylate
|
EGFR and ErbB-2/HER2 tyrosine kinase inhibitor |
€95.00 |
|
1970
|
Laquinimod
|
Selective autoimmune suppressant; Immunomodulator |
€95.00 |
|
1794
|
LB 42708
|
Inhibitor of farnesyltransferase (FTase) |
€95.00 |
|
1548
|
LBH 589
|
HDAC1 Inhibitor |
€95.00 |
|
2176
|
LCS-1
|
Inhibits SOD1 enzymatic activity. Lead compound for lung cancer therapeutics |
€85.00 |
|
2224
|
LDK 378
|
Potent, bioavailable, and selective anaplastic lymphoma kinase (ALK) inhibitor |
€95.00 |
|
1509
|
LDN 193189 hydrochloride
|
Highly potent small molecule inhibitor of BMP type I receptors ALK2, ALK3, and ALK6 |
€70.00 |
|
2260
|
LDN 212320
|
Activator of EAAT2 translation; neuroprotectant |
€90.00 |
|
2201
|
LDN 212854 trihydrochloride
|
Potent ALK2-biased BMP type I receptor kinase inhibitor |
€105.00 |